Cancers,
Год журнала:
2024,
Номер
16(23), С. 4078 - 4078
Опубликована: Дек. 5, 2024
Cisplatin-based
chemotherapy
has
long
been
the
standard
first-line
(1L)
treatment
for
metastatic
urothelial
carcinoma
(mUC).
However,
up
to
50%
of
patients
with
mUC
may
be
ineligible
cisplatin
owing
comorbidities,
necessitating
alternative
primary
options.
Immune
checkpoint
inhibitors
(ICIs)
have
emerged
as
a
vital
those
unable
receive
cisplatin.
Nevertheless,
prognosis
advanced
UC
remains
dire
and
challenges
persist
in
optimizing
1L
therapy.
Recent
medical
advancements
redirected
attention
towards
innovative
drug
combinations
mUC.
The
combination
enfortumab
vedotin
(EV)
pembrolizumab
shown
significantly
improved
overall
progression-free
survival
rates
compared
alone.
This
can
used
who
are
cisplatin-ineligible
or
require
alternatives
chemotherapy.
While
platinum-based
continues
essential
many
patients,
approval
EV
treatments
signifies
major
breakthrough
cancer
care.
These
therapies
offer
enhanced
outcomes
terms
response
highlight
increasing
relevance
ICI-containing
regimens
frontline
review
provides
an
exhaustive
overview
current
landscape
explores
new
therapeutic
strategies,
aim
facilitating
clinical
decision-making
guiding
strategies
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(13), С. 10858 - 10858
Опубликована: Июнь 29, 2023
Hepatocellular
carcinoma
(HCC)
is
the
most
common
primary
liver
tumor
and
often
diagnosed
at
an
unresectable
advanced
stage.
Systemic
chemotherapy
as
well
transarterial
chemoembolization
(TACE)
hepatic
arterial
infusion
(HAIC)
are
used
to
treat
HCC.
TACE
HAIC
have
long
been
standard
of
care
for
patients
with
HCC
but
limited
treatment
intrahepatic
lesions.
doxorubicin
or
chemohormonal
therapy
tamoxifen
also
considered,
neither
has
demonstrated
survival
benefits.
In
HCC,
cisplatin
administered
transhepatic
arterially
local
treatment.
Subsequently,
cisplatin-refractory
cases
due
drug
resistance,
a
shift
systemic
different
mechanism
action
expected
produce
new
antitumor
effects.
Cisplatin
tumors
other
than
This
review
summarizes
resistance
describes
major
hepatobiliary
cancers
which
anticancer
agent,
focus
on
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 945 - 945
Опубликована: Янв. 12, 2024
Chloroquine
(CQ)
and
its
derivate
hydroxychloroquine
(HCQ),
the
compounds
with
recognized
ability
to
suppress
autophagy,
have
been
tested
in
experimental
works
clinical
trials
as
adjuvant
therapy
for
treatment
of
tumors
different
origin
increase
efficacy
cytotoxic
agents.
Such
a
strategy
can
be
effective
overcoming
resistance
cancer
cells
standard
chemotherapy
or
anti-angiogenic
therapy.
This
review
presents
results
combined
application
CQ/HCQ
conventional
drugs
(doxorubicin,
paclitaxel,
platinum-based
compounds,
gemcitabine,
tyrosine
kinases
PI3K/Akt/mTOR
inhibitors,
other
agents)
malignancies
obtained
experiments
on
cultured
cells,
animal
xenografts
models,
few
trials.
The
effects
such
an
approach
viability
tumor
growth,
well
autophagy-dependent
-independent
molecular
mechanisms
underlying
cellular
responses
CQ/HCQ,
are
summarized.
Although
majority
vitro
vivo
studies
shown
that
effectively
sensitize
agents
potential
chemotherapy,
often
inconsistent.
Nevertheless,
pharmacological
suppression
autophagy
remains
promising
tool
increasing
development
more
specific
inhibitors
is
required.
Foods,
Год журнала:
2023,
Номер
12(8), С. 1733 - 1733
Опубликована: Апрель 21, 2023
Quercetin
is
an
antioxidant
phytochemical
which
belongs
to
the
natural
flavonoids
group.
Recently,
compound
has
been
reported
inhibit
glutathione
reductase
responsible
for
replenishing
reduced
forms
of
and
thus
leads
depletion,
triggering
cell
death.
In
this
study,
we
examined
if
quercetin
sensitizes
tumors
oxaliplatin
by
inhibiting
activity
in
human
colorectal
cancer
cells,
thereby
facilitates
apoptotic
A
combined
treatment
with
was
found
synergistically
activity,
lower
intracellular
level,
increase
reactive
oxygen
species
production,
reduce
viability,
compared
alone
HCT116
cells.
Furthermore,
incorporation
sulforaphane,
recognized
its
ability
scavenge
glutathione,
combination
oxaliplatin,
substantially
suppressed
tumor
growth
xenograft
mouse
model.
These
findings
suggest
that
depletion
sulforaphane
could
strengthen
anti-cancer
efficacy
oxaliplatin.
Cancers,
Год журнала:
2023,
Номер
15(21), С. 5136 - 5136
Опубликована: Окт. 25, 2023
High-grade
serous
ovarian
cancer
(HGSOC)
accounts
for
70%
of
cases,
and
the
survival
rate
remains
remarkably
low
due
to
lack
effective
long-term
consolidation
therapies.
Clinical
remission
can
be
temporarily
induced
by
platinum-based
chemotherapy,
but
death
subsequently
results
from
extensive
growth
a
platinum-resistant
component
tumor.
This
work
explores
novel
treatment
against
HGSOC
using
gold
complex
auranofin
(AF).
AF
primarily
functions
as
pro-oxidant
inhibiting
thioredoxin
reductase
(TrxR),
an
antioxidant
enzyme
overexpressed
in
cancer.
We
investigated
effect
on
TrxR
activity
various
mechanisms
cytotoxicity
cells
that
are
clinically
sensitive
or
resistant
platinum.
In
addition,
we
studied
interaction
between
another
pro-oxidant,
L-buthionine
sulfoximine
(L-BSO),
anti-glutathione
(GSH)
compound.
demonstrated
potently
inhibited
reduced
vitality
viability
regardless
their
sensitivities
showed
induces
accumulation
reactive
oxygen
species
(ROS),
triggers
depolarization
mitochondrial
membrane,
kills
inducing
apoptosis.
Notably,
AF-induced
cell
was
abrogated
ROS-scavenger
N-acetyl
cysteine
(NAC).
lethality
associated
with
activation
caspases-3/7
generation
DNA
damage,
effects
were
also
prevented
presence
NAC.
Finally,
when
L-BSO
combined,
observed
synergistic
cells,
which
mediated
further
increase
ROS
decrease
levels
GSH.
summary,
our
support
concept
used
alone
combination
kill
sensitivity
platinum,
suggesting
depletion
antioxidants
is
efficient
strategy
mitigate
course
this
disease.
Cisplatin
(CDDP),
carboplatin
(CP),
and
oxaliplatin
(OXP)
are
three
platinating
agents
clinically
approved
worldwide
for
use
against
a
variety
of
cancers.
They
canonically
known
as
DNA
damage
inducers;
however,
that
is
only
one
their
mechanisms
cytotoxicity.
CDDP
mediates
its
effects
through
damage-induced
transcription
inhibition
apoptotic
signalling.
In
addition,
targets
the
endoplasmic
reticulum
(ER)
to
induce
ER-stress,
mitochondria
via
mitochondrial
leading
ROS
production,
plasma
membrane
cytoskeletal
components.
CP
acts
in
similar
fashion
by
inducing
damage,
ER
stress.
Additionally,
also
able
upregulate
micro-RNA
activity,
enhancing
intrinsic
apoptosis.
OXP,
on
other
hand,
at
first
induces
all
same
CP,
yet
it
capable
immunogenic
cell
death
stress
can
decrease
ribosome
biogenesis
nucleolar
effects.
this
comprehensive
review,
we
provide
detailed
action
agents,
going
beyond
nuclear
include
cytoplasmic
impact
within
cancer
cells.
cover
current
clinical
limitations,
including
side
resistance.
Biomolecules,
Год журнала:
2025,
Номер
15(3), С. 350 - 350
Опубликована: Фев. 28, 2025
Two
new
Ru(II)
complexes,
mononuclear
[RuCl2(η6-p-cymene)(3,4-dmph-κN)]
(1)
and
the
binuclear
complex
[{RuCl(η6-p-cymene)}2(μ-Cl)(μ-3,4-dmph-κ2N,N′)]Cl
(2;
3,4-dmph
=
3,4-dimethylphenylhydrazine),
are
synthesized
experimentally
theoretically
structurally
characterized
utilizing
1H
13C
NMR
FTIR
spectroscopy,
as
well
DFT
calculations.
Degradation
product
of
2,
thus
([{RuCl(η6-p-cymene)}2(μ-Cl)(μ-3,4-dmph-κ2N,N′)][RuCl3(η6-p-cymene)]
(2b)
was
with
SC-XRD.
In
crystals
2b,
cationic
anionic
parts
interact
through
N-H...Cl
hydrogen
bridges.
The
spectrofluorimetric
measurements
proved
spontaneity
binding
processes
both
complexes
HSA.
Spin
probing
EPR
implied
that
1
2
decreased
amount
bound
16-doxylstearate
implicated
their
potential
to
bind
HSA
more
strongly
than
spin
probe.
cytotoxicity
assessment
against
MDA-MB-231
MIA
PaCa-2
cancer
cell
lines
demonstrated
a
clear
dose-dependent
decrease
in
viability
no
effect
on
healthy
HS-5
cells.
Determination
malondialdehyde
protein
carbonyl
concentrations
indicated
could
offer
protective
antioxidant
benefits
specific
contexts.
Gel
electrophoresis
showed
reduction
MMP9
activity
limiting
cells’
invasion.
annexin
V/PI
apoptotic
assay
results
exhibit
different
selectivity
towards
A
comparative
molecular
docking
analysis
binding,
specifically
targeting
acetylcholinesterase
(ACHE),
matrix
metalloproteinase-9
(MMP-9),
human
serum
albumin
(HSA),
distinct
interactions
for
each
complex.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 3015 - 3015
Опубликована: Март 5, 2024
Patients
with
cancer
die
from
cardiac
dysfunction
second
only
to
the
disease
itself.
Cardiotoxicity
caused
by
anticancer
drugs
has
been
emphasized
as
a
possible
cause;
however,
details
remain
unclear.
To
investigate
this
mechanism,
we
treated
rat
cardiomyoblast
H9c2
cells
sunitinib,
lapatinib,
5-fluorouracil,
and
cisplatin
examine
their
effects.
All
increased
ROS,
lipid
peroxide,
iron
(II)
levels
in
mitochondria
decreased
glutathione
peroxidase-4
GSH/GSSG
ratio.
Against
background,
mitochondrial
accumulates
through
unregulated
expression
of
haem
oxygenase-1
ferrochelatase.
Anticancer-drug-induced
cell
death
was
suppressed
N-acetylcysteine,
deferoxamine,
ferrostatin,
indicating
ferroptosis.
Anticancer
drug
treatment
impairs
DNA
inhibits
oxidative
phosphorylation
cells.
Similar
results
were
observed
hearts
cancer-free
rats
vitro.
In
contrast,
pterostilbene
inhibited
induction
ferroptosis
rescued
energy
restriction
induced
both
vitro
vivo.
These
findings
suggest
that
inhibition
are
mechanisms
which
cause
myocardial
damage.
As
ameliorates
these
mechanisms,
it
is
expected
have
significant
clinical
applications.
Pharmaceutics,
Год журнала:
2024,
Номер
16(8), С. 1047 - 1047
Опубликована: Авг. 6, 2024
Cancer
is
still
ranked
among
the
top
three
causes
of
death
in
30-
to
69-year-old
age
group
most
countries
and
carries
considerable
societal
macroeconomic
costs
that
differ
depending
on
cancer
type,
geography,
patient
gender.
Despite
advances
several
pharmacological
approaches,
lack
stability
specificity,
dose-related
toxicity,
limited
bioavailability
chemotherapy
(standard
therapy)
pose
major
obstacles
treatment,
with
multidrug
resistance
being
a
driving
factor
failure.
The
past
decades
have
been
stage
for
intense
research
activity
topic
nanomedicine,
which
has
resulted
many
nanotherapeutics
reduced
increased
bioavailability,
improved
pharmacokinetics
therapeutic
efficacy
employing
smart
drug
delivery
systems
(SDDSs).
Polymeric
micelles
(PMs)
become
an
auspicious
DDS
medicinal
compounds,
used
encapsulate
hydrophobic
drugs
also
exhibit
substantial
toxicity.
Through
preclinical
animal
testing,
PMs
pharmacokinetic
profiles
efficacy,
resulting
higher
safety
profile
drugs.
This
review
focuses
are
already
clinical
trials,
traveling
pathways
from
studies
until
introduction
market.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(5), С. 4843 - 4843
Опубликована: Март 2, 2023
This
review
article
presents
an
overview
of
the
equilibrium
studies
on
Pd-amine
complexes
with
bio-relevant
ligands
in
reference
to
their
antitumor
activity.
Pd(II)
amines
different
functional
groups,
were
synthesized
and
characterized
many
studies.
The
complex
formation
equilibria
Pd(amine)2+
amino
acids,
peptides,
dicarboxylic
acids
DNA
constituents,
extensively
investigated.
Such
systems
may
be
considered
as
one
models
for
possible
reactions
occurring
drugs
biological
systems.
stability
formed
depends
structural
parameters
ligands.
evaluated
speciation
curves
can
help
provide
a
pictorial
presentation
solutions
pH
values.
data
sulfur
donor
compared
those
reveal
information
regarding
deactivation
caused
by
donors.
binuclear
constituents
was
investigated
support
significance
this
class
complexes.
Most
studied
low
dielectric
constant
medium,
resembling
that
medium.
Investigations
thermodynamic
species
is
exothermic.